These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 7943771)
21. Allogeneic transfusion and infection: economic and clinical implications. Blumberg N Semin Hematol; 1997 Jul; 34(3 Suppl 2):34-40. PubMed ID: 9253782 [TBL] [Abstract][Full Text] [Related]
22. Changes in lymphocyte subsets and mitogen responsiveness following open-heart surgery and possible therapeutic approaches. Markewitz A; Faist E; Niesel T; Lang S; Weinhold C; Reichart B Thorac Cardiovasc Surg; 1992 Feb; 40(1):14-8. PubMed ID: 1385913 [TBL] [Abstract][Full Text] [Related]
23. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. MacIvor D; Nelson J; Triulzi D Transfusion; 2009 Jul; 49(7):1431-4. PubMed ID: 19320863 [TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients. Karger R; Stangenberg K; Hinrichs F; Griss P; Kretschmer V Transfus Med; 2004 Oct; 14(5):347-57. PubMed ID: 15500454 [TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Carrier M; Denault A; Lavoie J; Perrault LP Ann Thorac Surg; 2006 Jul; 82(1):51-5. PubMed ID: 16798186 [TBL] [Abstract][Full Text] [Related]
27. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Lapierre V; Aupérin A; Robinet E; Ferrand C; Oubouzar N; Tramalloni D; Saas P; Debaene B; Lasser P; Tiberghien P Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736 [TBL] [Abstract][Full Text] [Related]
28. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119 [TBL] [Abstract][Full Text] [Related]
29. Effect of packed red blood cells transfusion on plasma fibronectin during liver resection. Kostopanagiotou G; Pandazi A; Matsota P; Arkadopoulos N; Dalamanga N; Politou M; Traulou O; Smyrniotis V Transfus Med; 2007 Apr; 17(2):115-8. PubMed ID: 17430467 [TBL] [Abstract][Full Text] [Related]
30. Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery. Karger R; Weber C; Schmidt J; Kretschmer V Transfus Med; 2007 Feb; 17(1):45-53. PubMed ID: 17266703 [TBL] [Abstract][Full Text] [Related]
31. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation. Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931 [TBL] [Abstract][Full Text] [Related]
32. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Whitson BA; D'Cunha J; Hoang CD; Wu B; Ikramuddin S; Buchwald H; Panoskaltsis-Mortari A; Kratzke RA; Miller JS; Maddaus MA Surg Obes Relat Dis; 2009; 5(2):181-93. PubMed ID: 18996756 [TBL] [Abstract][Full Text] [Related]
33. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. Bilgin YM; van de Watering LM; Versteegh MI; van Oers MH; Brand A Crit Care Med; 2010 Feb; 38(2):546-52. PubMed ID: 19864941 [TBL] [Abstract][Full Text] [Related]
34. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Kwon AH; Matsui Y; Kamiyama Y Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035 [TBL] [Abstract][Full Text] [Related]
36. Utilization patterns of frozen autologous red blood cells. Experience in a referral center and a community hospital. DePalma L; Palmer R; Leitman SF; Dolan WD; Klein HG Arch Pathol Lab Med; 1990 May; 114(5):516-8. PubMed ID: 2334260 [TBL] [Abstract][Full Text] [Related]
37. Survival of erythrocytes after autologous and allogeneic transfusion in cats. Marion RS; Smith JE J Am Vet Med Assoc; 1983 Dec; 183(12):1437-9. PubMed ID: 6654723 [TBL] [Abstract][Full Text] [Related]
38. [Is preservation of erythrocyte concentrates with added solutions an alternative to deep freezing in heart surgery autologous blood donation?]. Behr W; Doukas K; Lang H; Plahl M; Struck E Beitr Infusionsther; 1990; 26():252-6. PubMed ID: 1703843 [TBL] [Abstract][Full Text] [Related]
39. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells. Innerhofer P; Luz G; Spötl L; Hobisch-Hagen P; Schobersberger W; Fischer M; Nussbaumer W; Lochs A; Irschick E Transfusion; 1999 Oct; 39(10):1089-96. PubMed ID: 10532603 [TBL] [Abstract][Full Text] [Related]
40. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. Perttilä J; Salo M; Pirttikangas CO; Jalonen J; Vainio O J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):532-5. PubMed ID: 7803741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]